ArticleHypertension research : official journal of the Japanese Society of Hypertension2026
Body mass index modifies cardiovascular risk across blood pressure categories, particularly among underweight adults with hypertension: a 6.3 million‑person nationwide Japanese cohort study.
Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Commented on by
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Co-occurring obesity and hypertension is associated with high cardiovascular risk, whereas the prognostic significance of underweight in the presence of hypertension remains uncertain. We examined whether the association between body mass index category and 10-year risk of major adverse cardiovascular events differed across blood pressure categories. Using the Japan Medical Claims Database from 2005 to 2023, we analyzed 6,262,298 adults without prior cardiovascular disease, chronic renal failure, dialysis, or antihypertensive medication use at baseline. Blood pressure was classified as normal (<120 and <80 mmHg), high-normal (120-129 and <80 mmHg), elevated (130-139 and/or 80-89 mmHg), stage 1 hypertension (140-159 and/or 90-99 mmHg), or stage 2/3 hypertension (≥160 and/or ≥100 mmHg). Body mass index was classified as underweight (<18.5 kg/m²), normal weight (18.5-24.9), overweight (25.0-29.9), or obesity (≥30.0). The primary outcome was major adverse cardiovascular events within 10 years. Multivariable Cox proportional hazards models estimated hazard ratios for combined blood pressure and body mass index categories, using normal blood pressure with normal weight as the reference. During a median follow-up of 1,183 days, 34,034 participants experienced major adverse cardiovascular events. Underweight showed a marked blood pressure-dependent increase in risk, with the hazard ratio rising from 1.14 (95% confidence interval, 1.07-1.22) in normal blood pressure to 5.01 (4.23-5.93) in stage 2/3 hypertension. The interaction between blood pressure category and body mass index category was significant. These findings suggest that higher blood pressure may amplify the adverse prognostic significance of underweight.
Indexed as
Identifiers
42675147What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.